Skip to main content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Grant Details

Grant Number: 5R01CA239178-02 Interpret this number
Primary Investigator: Berg, Carla
Organization: George Washington University
Project Title: Assessing Iqos Marketing Influences and Consumer Behavior in Israel: Implications for the Us
Fiscal Year: 2020


Abstract

SUMMARY/ABSTRACT The global market has increasingly included heated tobacco products (HTPs). Philip Morris International (PMI) submitted a Premarket Tobacco Application for IQOS, the global HTP leader, and is pursuing Modified Risk Tobacco Product categorization for this product. Given the impending introduction of IQOS into the US market, it is critical to leverage marketing data from other contexts to inform and advance regulatory efforts regarding IQOS. This proposal leverages a scientific premise and a conceptual framework based on a Socioecological Framework, indicating the importance of regulatory contexts and implications for marketing, and Diffusion of Innovation Theory, accounting for marketing strategies and channels, as well as impact on consumer behavior and perceptions. At the policy level, while there are several countries in which IQOS has a presence in the market, Israel is unique in that it represents 3 distinct regulatory contexts: 1) during IQOS’s initial emergence in Israel, it was not categorized as a tobacco product (Dec 2016-Apr 2017); 2) it was classified as a tobacco product in a relatively weak regulatory context (Apr 2017- 2019); and 3) it will be regulated as a tobacco product within new progressive legislation (going into effect beginning 2019). Our study team has been collecting and analyzing IQOS marketing data in Israel since 2016; thus, we are strategically positioned to compare real-world marketing strategies used by PMI in these different regulatory contexts and to examine consumer reactions to this marketing content in both Israel and the US. PMI’s IQOS website suggests targeting at least 4 consumer market segments (business & current events; art, culture & fashion; nature & hiking; innovation & technology). Thus, their marketing content and distribution channels likely reflect these groups. However, these segments may be differentially prioritized by PMI marketing and may be distinct in their likely IQOS use and perceptions. In summary, the Israeli regulatory context and our prior research offers an opportunity to advance US readiness to regulate IQOS marketing. This will be critical, given that independent research is needed, particularly using real-world marketing and borrowing from the industry’s own methods, in order to truly estimate population impact of such products and their marketing. The overall goal of this line of work is to inform tobacco regulatory efforts to minimize population harm of tobacco use. To this end, the immediate objective is to examine IQOS marketing strategies used in Israel during 3 regulatory periods and examine their impact on segments of the Israel and US population. We propose 2 inter-related specific aims: 1) examine IQOS marketing strategies in Israel from its emergence in the Israel market; and 2) examine market segments of Israeli and US adults in relation to IQOS use and/or likelihood of future use. This proposal is responsive to RFA-OD-18-002, focusing on marketing influences and behavior, and involves innovative applications of rigorous methodology. By examining PMI’s IQOS marketing strategies used in the 3 different regulatory periods in Israel and understanding the impact of these strategies on different segments of consumers and the extent to which they generalize to US consumers, findings will provide information to better estimate the potential impact of IQOS and its marketing in the US.



Publications

Vape shop owners'/managers' attitudes about CBD, THC, and marijuana legal markets.
Authors: Berg C.J. , Getachew B. , Pulvers K. , Sussman S. , Wagener T.L. , Meyers C. , Park A. , Dorvil S. , Patterson A. , Weber A. , et al. .
Source: Preventive medicine reports, 2020 Dec; 20, p. 101208.
EPub date: 2020-09-12.
PMID: 32995147
Related Citations

A systematic review of practice-, provider-, and patient-level determinants impacting Asian-Americans' human papillomavirus vaccine intention and uptake.
Authors: Vu M. , Berg C.J. , Escoffery C. , Jang H.M. , Nguyen T.T. , Travis L. , Bednarczyk R.A. .
Source: Vaccine, 2020-09-22; 38(41), p. 6388-6401.
EPub date: 2020-08-20.
PMID: 32829979
Related Citations

Smokers' and Nonsmokers' Receptivity to Smoke-Free Policies and Pro- and Anti-Policy Messaging in Armenia and Georgia.
Authors: Topuridze M. , Berg C.J. , Dekanosidze A. , Torosyan A. , Grigoryan L. , Bazarchyan A. , Sargsyan Z. , Hayrumyan V. , Maglakelidze N. , Sturua L. , et al. .
Source: International journal of environmental research and public health, 2020-07-30; 17(15), .
EPub date: 2020-07-30.
PMID: 32751714
Related Citations

Informing iQOS Regulations in the United States: A Synthesis of What We Know.
Authors: Berg C.J. , Bar-Zeev Y. , Levine H. .
Source: SAGE open, 2020 Jan-Mar; 10(1), .
EPub date: 2020-01-09.
PMID: 32719733
Related Citations

IQOS point-of-sale marketing strategies in Israel: a pilot study.
Authors: Bar-Zeev Y. , Levine H. , Rubinstein G. , Khateb I. , Berg C.J. .
Source: Israel journal of health policy research, 2019-01-14; 8(1), p. 11.
EPub date: 2019-01-14.
PMID: 30642383
Related Citations




Back to Top